Get startedLog in
    Picture of Eckert & Ziegler SE logo

    EUZ — Eckert & Ziegler SE News Story

    0.000.00%
    de flag iconLast trade - 00:00
    HealthcareAdventurousMid CapFalling Star
    All News

    Brief: Eckert & Ziegler To Supply Ablaze Pharmaceuticals With Lutetium-177 For Clinical Trials

    Picture of Eckert & Ziegler SE logoEckert & Ziegler SE
    23/10/2023 08:03
    Oct 23 (Reuters) - ECKERT & ZIEGLER STRAHLEN UND
MEDIZINTECHNIK AG  EUZG.DE :
    * ECKERT & ZIEGLER TO SUPPLY ABLAZE PHARMACEUTICALS WITH
LUTETIUM-177 FOR CLINICAL TRIALS
    * TO SUPPLY ABLAZE PHARMACEUTICALS WITH LUTETIUM-177 FOR
CLINICAL
TRIALS
    * AND ABLAZE PHARMACEUTICALS (ABLAZE) SIGNED A COMPREHENSIVE
SUPPLY AGREEMENT FOR NON-CARRIER ADDED LUTETIUM-177 (N.C.A.
177LU). ECKERT & ZIEGLER WILL SERVE AS SUPPLIER FOR ABLAZE'S
CLINICAL TRIAL AND RESEARCH ACTIVITIES UTILIZING LUTETIUM-177

Source text for Eikon:  ID:nEQ1yP6Fka 
Further company coverage:  EUZG.DE 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Eckert & Ziegler SE

    See all news